DoW Breast Cancer, Transformative Breast Cancer Consortium Award
Department of Defense
Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Award supports collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. Applications must propose a synergistic, highly integrated, multidisciplinary and multi-institutional consortium of leading scientists, clinicians and breast cancer consumer advocates that will address a major problem in a way that a single investigator or group could not accomplish. The consortium’s collaborative efforts must make a transformative impact in breast cancer. All applicat
Funding
Award size
Not specified
Type
Cooperative Agreement
Dates
Deadline
Next 90 days
Posted
05/04/2026
Closes
2026-09-30
Eligibility
Eligibility
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Program
Funding area
Science and Technology and other Research and Development - ST
Opportunity #
HT942526BCRPTBCCA
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov